Bringing the fundamentals into focus…
Back to Vir Biotechnology, Inc.
How Vir Biotechnology, Inc. stacks up
VIR · against 416 other Healthcare companies of similar size
Profitability
18/ 100
Near the bottom of its peers.
Ranked #348 of 417 · scores higher than 15% of peers
Bars: peers in each 10-point band of the profitability score40 peers with a profitability score of 10–19, including VIR · Click a bar to see the companies
Why profitability scores 18?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 87% of peers. Operating margin: -92.4% vs peer median 7.1%
- a lower return on invested capital: weaker than 83% of peers. Return on invested capital: -31.5% vs peer median 4.7%
- a lower return on assets: weaker than 81% of peers. Return on assets: -20.7% vs peer median 1.7%
Metric by metric
Position: dot = VIR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VIR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 392 reported | -31.5% | 5.8% | 15% | 33% | |
| Operating marginHigher is better · 384 reported | -92.4% | 7.9% | 10% | 33% | |
| Return on assetsHigher is better · 400 reported | -20.7% | 2.0% | 16% | 33% | |
| Return on equityHigher is better · 385 reported | -26.1% | 4.9% | 22% | Context only | |
| Gross marginHigher is better · 431 reported | -59.4% | 47.8% | 1% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around VIR| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 348 | 1.6B USD | 18 | 38 | |
| 348 | 1.6B USD | 18 | 7 | |
| 348 | 994M USD | 18 | 39 | |
| 348 | 1.7B USD | 18 | 31 | |
| 348 | 1.9B USD | 18 | 42 | |
| 356 | 1.0B EUR (≈$1.1B) | 17 | 16 | |
| 356 | 1.9B USD | 17 | 32 | |
| 358 | 1.5B USD | 16 | 26 | |
| 358 | 1.1B USD | 16 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score